Aarkstore - Oncology Research Digest H1 2014 (1)

1
Oncology Research Digest H1 2014
Category Pharmaceuticals Healthcare Market
www.aarkstore.com
2
Summary

• The Oncology Research Digest is a digest of all
  the most important research in the oncology
  market each quarter, and available as an annual
  subscription. It covers areas such as
  biosimilars, novel immunotherapies, non-small
  cell lung cancer, pancreatic cancer, bladder
  cancer, breast cancer, ovarian cancer and drugs
  such as Rituxan, Avastin, Herceptin, Traceva,
  Xeloda, Gleevec, Revlimid, Alimta, Velcade. It is
  gathered from over 50 sources including
  associations, consultants, market intelligence
  companies, investment banks, and industry
  participants.

www.aarkstore.com
3
Updated quarterly, the Digest allows you to 

• Quickly update yourself on the latest research
  findings, gathered and organised for you.
• Get our Expert Analysts perspectives on the
  latest research.
• Link through to the original research to
  review or purchase.

Browse Complete Report - http//www.aarkstore.com/
pharmaceuticals-healthcare/94728/oncology-research
-digest-h1-2014
www.aarkstore.com
4
Executive Summary

• Oncology Research Digest H1 2014 finds that the
  cancer market is successfully adapting to
  challenges. Patent expires and payer pressures
  have led to relatively slow growth in the cancer
  market in the last five years, and this will
  continue to be a feature. However the launch of
  new drugs for the treatment of various types of
  cancers including lung, blood and pancreatic
  cancer are expected to drive growth. New drugs
  will also drive global markets for Non-Small Cell
  Lung Cancer, Anti- Cancer and Lymphocytic Cancer.
  These new products will change the shape of the
  market, with players such as Johnson and Johnson
  coming to the fore.In terms of geographies, the
  US market continues to lead with the prices of
  cancer drugs and treatment costs increasing due
  to the shift in the US healthcare system. The
  Asia Pacific region looks the most attractive
  geography in terms of potential, however the
  Indian and Chinese markets remain hindered by
  local market factors. 

www.aarkstore.com
5
Some highlights from the Digest include

• Global Prostate Cancer Therapeutics Market Has
  Good Commercial Potential Physicians in China
  Prescribe Less Expensive Drugs First Caribbean
  Countries Present Opportunities for
  Pharmaceutical Companies Johnson Johnson to
  Emerge as a Key Oncology Player Shift in the US
  Health Care Systems Increased the Cost of Cancer
  Treatment Branded Drugs Adoption to Drive
  Breast Cancer Market

www.aarkstore.com
6
Table of Content

• 1_Global Oncology Research1.1._Global Oncology
  Spending Growth Declined (2008-2013)1.2._Who Are
  The Leading Players In the Cancer Drugs Market in
  2013 and 2018?1.3._Johnson Johnson to Emerge
  as a Key Oncology Player1.4._New Drugs Launch
  Will Expand Global Market Size for Anti-Cancer
  Kinase Inhibitor Drugs1.5._Biosimilars
  Contribution in Biologics Market for Oncology
  Treatment Remains Low1.6._Immunotherapies Have
  Potential for Non-Small Cell Lung Cancer
  Treatment1.7._Global Cancer Immunotherapy Market
  Expected To Soar To 20221.8._Pancreatic Cancer
  Treatment Market Forecast to Grow Slowly1.9._New
  Drugs to Drive Chronic Lymphocytic Leukemia
  Treatment Market1.10._Bladder Cancer Market Will
  Grow Slowly1.11._Breast Cancer the Second Most
  Common Cancer Globally1.12._Branded Drugs
  Adoption to Drive Breast Cancer
  Market1.13._Ovarian Cancer Therapeutics Market
  Growth Minimized By Approved Therapies Shortage

www.aarkstore.com
7
Table of Content

• 2_The Americas Oncology Research2.1._Prices of
  Cancer Drugs Increasing In the USA2.2._Shift in
  the US Health Care Systems Have Increased the
  Cost of Cancer Treatment2.3._Caribbean Countries
  Present Opportunities for Pharmaceutical
  Companies2.4._Prostate Cancer The Second
  Leading Cause of Cancer Death in Men in the USA
• 3_Asia Pacific Oncology Research3.1._Asia
  Accounts for Nearly Half of the Total Global
  Cancer Incidence3.2._Asian NSCLC Treatment
  Market Will Grow Only Marginally In Spite of
  Expected Drug Launches3.3._Increased Adoption of
  Branded Drugs Expands Breast Cancer Market in
  Asia-Pacific Region3.4._Chinas Gastric Cancer
  Drug Market Increased after Herceptins Approval
  to Treat Gastric Cancer3.5._Physicians in China
  Prescribe Less Expensive Drugs First3.6._Absence
  of Reimbursement Limits Breast Cancer Treatment
  in China3.7._Issues for Foreign Pharmaceutical
  Companies in China

www.aarkstore.com
8
Related Reports

• Peritoneal Cancer - Pipeline Review, H1 2015
• Oral Mucositis - Pipeline Review, H1 2015
• Bacterial Vaginosis - Pipeline Review, H1 2015
• Prader-Willi Syndrome (PWS) - Pipeline Review, H1
  2015
• Sedation - Pipeline Review, H1 2015
• Cystic Fibrosis Market in Europe 2015-2019
• Global Ultrasound Equipment Market 2015-2019
• Lung Cancer-Global API Manufacturers, Marketed
  and Phase III Drugs Landscape, 2015
• Melanoma-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015

www.aarkstore.com
9
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news

www.aarkstore.com